The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Richard Penny of Crux Asset Management has a few comments on BVC worth listening to [29.20 mins in], highlighting the complete disconnect between the SP and sum of the parts valuation. The divestment of non core assets could spark a rerating.
There's a an interesting extract in today's DM from 'How not to age' by Dr Michael Greger focusing on healthy eating.
Perhaps the most poignant line of all is 'Excess salt appears to be humanity's number one dietary risk factor for death'
If the trained teams of 'super tasters' at the likes of PepsiCo conclude that our product has no unpleasant metallic or bitter notes when added to certain foods [as is the case with current low salt alternatives] we could be on to something very big indeed.
I've just read the Times reader's comments and concluded that this must be one of the most loathed stocks in the FTSE Aim All Share. If I were Basu, I think I'd keep a low profile having lost so many investors so much money over the years. I definitely wouldn't crow about turning EBITDA positive. We're not that stupid!
How sad that the UK is not longer regarded as a fiscally stable place to invest. With the right policies we could have nurtured a domestic energy champion in HBR but instead have driven the investment abroad. We can now import the gas instead creating a bigger carbon footprint and add to our ballooning balance of trade deficit. Imbecilic decisions to woo a few popular votes sadly have real repercussions.
Yes, incredible. Now equivalent to 159p on the bid price. Even after today's confirmatory RNS I must be missing something but will continue buying in my SIPP. Worst case scenario is the deal falls through but in the long term still trading at a huge discount to NAV and value will out in the end.
In the RNS of 19.6 it states that the company has 'a very significant pool of UK tax losses which total in excess of £150M'
If PMG merged with another NS company with significant production, does this mean it could be worth up to 40% of this i.e. £60M? I'm sure that cannot be correct as it would make PMG ridiculously undervalued. Perhaps someone could enlighten me on how this works. [I am aware that it cannot be used to offset the 35%EPL]
Well spotted.
'Whilst a placement of NetScientific shares remains an available option, the Board has no current intention to pursue that in light of the Company's current share price relative to its net assets.'
This is reassuring as another placement at a ludicrous discount would be a huge negative.
Having read this more than happy to add given massive value on offer.
I only wish that Basu exercised the same discipline with corporate capital as he does with his personal finances [allowing significant dilution of his own stake with a piffling uptake of new shares]
It's hard to believe that the OO was so heavily oversubscribed when it should be easy to buy in the market well below this in the days to come.
I wonder how long £8m will keep the lights on? Not long given their track record and prodigious cash burn.
Next placing at 0.5p?